Concepedia

Daniel Meraviglia-Crivelli

DM

Statistics

Publications

5

Citations

155

H-Index

5

Active since

2018

Affiliations

Navarre Institute of Health Research(Current)

Complejo Hospitalario de Navarra

Universidad de Navarra

Yale University

Daniel Meraviglia-Crivelli is an author at Navarre Institute of Health Research specializing in oncology, life sciences, and antitumor immune activation.

ORCID

Publications per year

2018–2022

5

Publications

5

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

Mario Martínez Soldevilla, Helena Villanueva, Daniel Meraviglia-Crivelli et al. · Molecular Therapy · 2019 · 50 citations · Full text

, , +17

IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction

Daniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva et al. · Molecular Cancer · 2022 · 33 citations · Full text

, , +17

Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals

Javier Arranz‐Nicolás, Jesús Ogando, Denise Soutar et al. · Cancer Immunology Immunotherapy · 2018 · 32 citations · Full text

, , +16

A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

Daniel Meraviglia-Crivelli, Helena Villanueva, Ashwathi Puravankara Menon et al. · Molecular Therapy — Nucleic Acids · 2022 · 30 citations · Full text

, , +14

Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors

Mario Martínez Soldevilla, Helena Villanueva, Naiara Martínez-Vélez et al. · OncoImmunology · 2018 · 10 citations · Full text

, , +17

1–5 of 5